FDC
Back to Balance Sheet
|
FDC Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹812 Cr | ₹604 Cr | ₹469 Cr | ₹391 Cr | ₹300 Cr |
What is the latest Total Non-Current Liabilities ratio of FDC ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹812 Cr |
Mar2024 | ₹604 Cr |
Mar2023 | ₹469 Cr |
Mar2022 | ₹391 Cr |
Mar2021 | ₹300 Cr |
How is Total Non-Current Liabilities of FDC Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹812 Cr | 34.38 | |
Mar2024 | ₹604 Cr | 28.92 | |
Mar2023 | ₹469 Cr | 19.81 | |
Mar2022 | ₹391 Cr | 30.55 | |
Mar2021 | ₹300 Cr | - |
Compare Total Non-Current Liabilities of peers of FDC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
FDC | ₹7,570.2 Cr | -1.2% | -4.1% | -18.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹386,197.0 Cr | 0.9% | -0.2% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,634.0 Cr | 0.1% | 0.4% | 16.6% | Stock Analytics | |
CIPLA | ₹126,082.0 Cr | 0.5% | 3.8% | -3.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,167.0 Cr | NA | -0.9% | 4.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,783.0 Cr | 2.8% | 6.9% | -2% | Stock Analytics |
FDC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
FDC | -1.2% |
-4.1% |
-18.4% |
SENSEX | 1% |
2.1% |
0.5% |
You may also like the below Video Courses